Front Matter

Chapters in this book

1. Front Matter i
2. Contents v
3. Acknowledgments ix
4. Abbreviations xi
5. Introduction: Making Sense of Emerging Technologies 3
6. Hindsight Learnings
7. GM Foods in Hindsight 13
8. Patentable Subject Matter: Who Owns What Knowledge? 33
9. Patents in the Public Sphere: Public Perceptions and Biotechnology Patents 51
10. Foresight Applications
11. (Transgenic) Animal Farm
12. Of Biotechnology and Blind Chickens 69
13. Transgenic Salmon: Regulatory Oversight of an Anticipated Technology 81
14. Fields of Pharmas: Plant Molecular Farming
15. The Emerging Technology of Plant Molecular Farming 101
16. Policy and Regulatory Challenges for Plant-Made Pharmaceuticals in the United States 120
17. Forestalling Liabilities? Stakeholder Participation and Regulatory Development 138
18. In the Stem Cell Fields
19. When Human Dignity Is Not Enough: Embryonic Stem Cell Research and Human Cloning in Canada 161
20. Drugs–Up Close and Personal: Engaging Pharmacogenomics
21. Banking on Trust: Issues of Informed Consent in Pharmacogenetic Research 185
22. Pharmacogenomic Promises: Reflections on Semantics, Genohype, and Global Justice 203
23. Envisioning Race and Medicine: BiDil and the Insufficient Match between Social Groups and Genotypes 221
24. Is Small Really Beautiful? Does Size Matter? Nanotechnologies
25. Nanotechnology and Human Imagination 241
26. Nanotechnology: The Policy Challenges 252
27. Governance Challenges and Emerging Technologies
28. Technology, Democracy, and Ethics: Democratic Deficit and the Ethics of Public Engagement 275
29. Impact Assessments and Emerging Technologies: From Precaution to “Smart Regulation”? 289
30. Technology Ownership and Governance: An Alternative View of IPRs 307
31. Conclusion: Reflections on Emerging Technologies 327
32. Contributors 335
33. Index 339